UNITED STATESSECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
For the quarterly period ended March 31, 2008
For the transition period from to
Commission File Number: 001-33549
Care Investment Trust Inc.
(Exact name of Registrant as specified in its charter)
505 Fifth Avenue, 6th Floor, New York, New York 10017
(Address of Registrant’s principal executive offices)
(212) 771-0505
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of ‘‘large accelerated filer’’ and ‘‘accelerated filer’’ and ‘‘smaller reporting company’’ in Rule 12b-2 of the Exchange Act (check one):
Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 under the Securities Exchange Act of 1934. Yes No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practical date.
As of May 7, 2008, there were 21,004,323 shares, par value $0.001, of the registrant’s common stock outstanding.
2
Part I — Financial Information
ITEM 1. Financial Statements
Care Investment Trust Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)(dollars in thousands — except share and per share data)
See Notes to Condensed Consolidated Financial Statements.
3
Condensed Consolidated Statement of Operations (Unaudited)(dollars in thousands — except share and per share data)
4
Condensed Consolidated Statement of Stockholders’ Equity (Unaudited)(dollars in thousands, except share data)
5
Condensed Consolidated Statement of Cash Flows (Unaudited)(dollars in thousands)
6
Care Investment Trust Inc. and Subsidiaries — Notes to Condensed Consolidated Financial Statements (Unaudited)
March 31, 2008
Note 1 — Organization
Care Investment Trust Inc. (‘‘we,’’ ‘‘Care’’ or the ‘‘Company’’), was incorporated in Maryland on March 26, 2007, as a real estate and finance company formed principally to invest in healthcare-related commercial mortgage debt and real estate. The Company was formed, and is externally managed by, CIT Healthcare LLC (‘‘CIT Healthcare’’ or the ‘‘Manager’’), a wholly-owned subsidiary of CIT Group Inc. (‘‘CIT’’) to leverage the Manager’s expertise and relationships in the healthcare marketplace. In its capacity as Manager, CIT Healthcare identifies assets for acquisition and performs loan origination, servicing and other activities on behalf of the Company. We commenced operations on June 22, 2007; therefore, there is no prior year data available for comparison.
Care invests in healthcare real estate assets that are consistent with our investment guidelines, such as medical office buildings and senior housing facilities (independent and assisted living, and continuing care facilities). We also provide financing to companies operating a full range of healthcare-related facilities, including medical office buildings, skilled nursing facilities, hospitals, outpatient centers, surgery centers, senior housing, laboratories and other healthcare facilities. We provide mortgage financing secured by these healthcare facilities, including first lien mortgage loans, mezzanine loans, B Notes and construction loans.
Care elected to be taxed as a real estate investment trust, or ‘‘REIT’’ under the Internal Revenue Code commencing with our taxable year ended December 31, 2007. To maintain our tax status as a REIT, we are required to distribute at least 90% of our REIT taxable income to our stockholders. At present, Care does not have any taxable REIT subsidiaries (‘‘TRS’’), but in the normal course of business expects to form such subsidiaries as necessary.
Note 2 — Significant Accounting Policies
Basis of Quarterly Presentation
The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (‘‘GAAP’’) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnote disclosures required by GAAP for complete financial statement presentation. Financial statements in this Form 10-Q are unaudited, but in the opinion of management include all adjustments, consisting only of normal recurring adjustments, considered necessary for fair presentation. Results of operations for interim periods are not necessarily representative of results expected for the full year.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.
Consolidation
The consolidated financial statements include our accounts and those of our subsidiaries, which are wholly-owned or controlled by us. Significant intercompany balances and transactions have been eliminated.
Investments in partially-owned entities where the Company exercises significant influence over operating and financial policies of the subsidiary, but does not control the subsidiary, are reported under the equity method of accounting. Generally under the equity method of accounting, the Company’s share of the investee’s earnings or loss is included in the Company’s operating results.
7
FIN No. 46R, Consolidation of Variable Interest Entities, requires a company to identify investments in other entities for which control is achieved through means other than voting rights (‘‘variable interest entities’’ or ‘‘VIEs’’) and to determine which business enterprise is the primary beneficiary of the VIE. A variable interest entity is broadly defined as an entity where either the equity investors as a group, if any, do not have a controlling financial interest or the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company consolidates investments in VIEs when it is determined that the Company is the primary beneficiary of the VIE at either the creation of the variable inte rest entity or upon the occurrence of a reconsideration event. The Company has concluded that neither of its partially-owned entities are VIEs.
Segment Reporting
Statement of Financial Accounting Standards (‘‘SFAS’’) No. 131, Disclosures about Segments of an Enterprise and Related Information, establishes standards for the way that public entities report information about operating segments in the financial statements. We are a REIT focused on originating and acquiring healthcare-related real estate and commercial mortgage debt and currently operate in only one reportable segment.
Cash and Cash Equivalents
We consider all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Included in cash and cash equivalents at March 31, 2008, are approximately $3.0 million in borrowers’ deposits maintained in an unrestricted account. In addition, under the terms of the Master Repurchase Agreement for our warehouse line of credit with Column Financial, Inc., we are required to maintain minimum liquidity of $10 million under the current level of the line usage (See Note 6).
Real Estate
Real estate is carried at cost, net of accumulated depreciation and amortization. Betterments, major renewals and certain costs directly related to the acquisition, improvement and leasing of real estate are capitalized. Maintenance and repairs are charged to operations as incurred. Depreciation is provided on a straight-line basis over the assets’ estimated useful lives which range from 7 to 40 years. Tenant allowances are amortized on a straight-line basis over the lives of the related leases, which approximate the useful lives of the assets.
Upon the acquisition of real estate, we assess the fair value of acquired assets (including land, buildings and improvements, and identified intangibles such as above and below market leases and acquired in-place leases and customer relationships) and acquired liabilities in accordance with Statement of Financial Accounting Standards (‘‘SFAS’’) No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets, and we allocate purchase price based on these assessments. We assess fair value based on estimated cash flow projections that utilize appropriate discount and capitalization rates and available market informatio n. Estimates of future cash flows are based on a number of factors including the historical operating results, known trends, and market/economic conditions that may affect the property.
Our properties, including any related intangible assets, are reviewed for impairment if events or circumstances change indicating that the carrying amount of the assets may not be recoverable. An impairment exists when the carrying amount of an asset exceeds the aggregate cash flows over our anticipated holding period on an undiscounted basis. An impairment loss is measured based on the excess of the carrying amount over the discounted cash flows using an appropriate discount rate. The evaluation of anticipated cash flows is subjective and is based, in part, on assumptions regarding future occupancy, rental rates and capital requirements that could differ materially from actual results. Holding properties over longer periods decreases the likelihood of recording an impairment loss. If our anticipated holding periods change or estimated cash flows decline based on market conditions or otherwise, an impairment loss may be recognized.
8
Deferred Financing Costs
Deferred financing costs represent commitment fees, legal and other third party costs associated with obtaining commitments for financing which result in a closing of such financing. These costs are amortized over the terms of the respective agreements on the effective interest method and the amortization is reflected in interest expense. Unamortized deferred financing costs are expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financing transactions which do not close are expensed in the period in which it is determined that the financing will not close. See Note 6 for more information.
Concentrations of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash investments, loan investments and interest receivable. We may place our cash investments with high quality financial institutions. We perform ongoing analysis of credit risk concentrations in our loan investment portfolio by evaluating exposure to various markets, underlying property types, investment structure, term, sponsors, tenant mix and other credit metrics. The collateral securing our loan investments are real estate properties located in the United States.
New Accounting Pronouncements
On January 1, 2008, the Company adopted SFAS No. 157, Fair Value Measurements, which refines the definition of fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosures about fair value measurements. SFAS No. 157 defines fair value as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In addition, SFAS No. 157 encourages maximization of the use of market-based inputs over entity-specific inputs and requires disclosure in the form of an outlined hierarchy the details of fair value measurements. See Note 8 for more information.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities — Including an amendment of FASB Statement No. 115. This statement permits companies to measure many financial instruments and certain other items at fair value. SFAS 159 is effective for the Company on January 1, 2008. The Company did not elect the fair value option for any of its existing financial instruments on the effective date and has not determined whether or not it will elect this option for any eligible financial instruments it acquires in the future.
In June, 2007, the American Institute of Certified Public Accountants (AICPA) issued Statement of Position (SOP) 07-1, Clarification of the Scope of the Audit and Accounting Guide Investment Companies and Accounting for Parent Companies and Equity Method Investors for Investments in Investment Companies. This SOP provides guidance for determining whether an entity is within the scope of the AICPA Audit and Accounting Guide Investment Companies (the Guide). Entities that are within the scope of the Guide are required, among oth er things, to carry their investments at fair value, with changes in fair value included in earnings. The provisions of this SOP have been deferred indefinitely.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements — an amendment of ARB No. 51. SFAS 160 requires that a noncontrolling interest in a subsidiary be reported as equity and the amount of consolidated net income specifically attributable to the noncontrolling interest be identified in the consolidated financial statements. It also calls for consistency in the manner of reporting changes in the parent’s ownership interest and requires fair value measurement of any noncontrolling equity investment retained in a deconsolidation. SFAS 160 is effective for the Company on January 1, 2009. The Company is currently evaluating the impact adopting SFAS 160 will have on its consolidated financial statements.
In December 2007, the FASB issued SFAS 141R, Business Combinations. SFAS 141R broadens the guidance of SFAS 141, extending its applicability to all transactions and other events in which one entity obtains control over one or more other businesses. It broadens the fair value measurement and recognition of assets acquired, liabilities assumed, and interests transferred as a result of business
9
combinations. SFAS 141R expands on required disclosures to improve the statement users’ abilities to evaluate the nature and financial effects of business combinations. SFAS 141R is effective for the Company on January 1, 2009. The Company does not expect the adoption of SFAS 141R to have a material effect on its consolidated financial statements.
On March 20, 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133. SFAS 161 provides for enhanced disclosures about how and why an entity uses derivatives and how and where those derivatives and related hedged items are reported in the entity’s financial statements. SFAS 161 also requires certain tabular formats for disclosing such information. SFAS 161 is effective for the Company on January 1, 2009 with early application encouraged. SFAS 161 applies to all entities and all derivative instruments and related hedged items accounted for under SFAS 133. Among other things, SFAS 161 requires disclosures of an entity’s objectives and strategies for using deriv atives by primary underlying risk and certain disclosures about the potential future collateral or cash requirements (that is, the effect on the entity’s liquidity) as a result of contingent credit-related features. The Company is currently evaluating the impact that the adoption of SFAS 161 will have on the disclosures included in its consolidated financial statements.
Note 3 — Investments in Loans
As of March 31, 2008, our net investments in loans amounted to $246.2 million and consisted of $243.7 million in principal and $3.5 million in premium on the initial portfolio, offset by approximately $1.0 million in unamortized loan fees. For the three months ended March 31, 2008, we recorded $10.3 million of new originations generated by our Manager and $0.6 million to existing portfolio clients. In addition, the Company received approximately $1.2 million in loan amortizations and other loan-related payments. We recognized $0.2 million related to amortization of the premium we paid for the purchase of our initial assets from our Manager as a reduction of interest income.
10
Our investments include senior whole loans and participations secured primarily by real estate property in the form of pledges of ownership interests, direct liens or other security interests. The investments are in various geographic markets in the United States. These investments are all variable rate at March 31, 2008, had a weighted average spread of 3.43% over one month LIBOR, and an average maturity of approximately three years. The effective yield on the portfolio for the period for the three months ended March 31, 2008, was 7.85%. As of March 31, 2008, we held the following loan investments (in thousands):
All loans were paying in accordance with their terms as of March 31, 2008. Eight loans secured by first mortgages with a total principal balance of $116.6 million were pledged as collateral at March 31, 2008, for borrowings under our warehouse line of credit (see Note 6).
11
Our mortgage portfolio (gross) at March 31, 2008, is diversified by property type and U.S. geographic region as follows:
At March 31, 2008, our portfolio of sixteen mortgages was extended to thirteen borrowers with the largest exposure to any single borrower at 13.9% of the carrying value of the portfolio. The carrying value of five other loans, each to different borrowers with exposures of more than 10% of the carrying value of the total portfolio, amounted to 55.4%.
Note 4 — Investments in Partially-owned Entities
For the three months ended March 31, 2008, our equity in the loss of Cambridge amounted to $1.4 million and we incurred an additional $0.1 in deferred expenses. As distributions under our partnership agreement are made quarterly in arrears, we received no payments during the first quarter in operation. The Company’s investment in the Cambridge entities was $64.3 million. Summarized financial information for our unconsolidated joint venture with Cambridge at March 31, 2008 follows:
For the three months ended March 31, 2008, we recognized $0.3 million in equity income from our interest in SMC and received $0.2 million is distributions.
Note 5 — Investment in Net Leased Property
On March 31, 2008, Care acquired Sioux City II, a 35 unit Alzheimer’s facility in Sioux City, Iowa, from Bickford Senior Living Group, LLC, a wholly owned subsidiary of EBY Realty Group, LLC, for $3.5 million, and entered into a sale leaseback arrangement with the seller who remains as the operator of the property. The property is triple-net leased to the operator for fifteen years at an initial lease rate equal to 9% of the purchase price with 3% annual escalations. As the transaction closed on March 31, 2008, there is no income or loss recorded related to this investment for the period ended March 31, 2008.
At acquisition, the Company completed a preliminary assessment of the allocation of fair value of the acquired assets (including land, building, equipment and in-place leases) in accordance with SFAS No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets. Based on this assessment, approximately $0.2 million was allocated to equipment and $0.4 million of
12
the purchase price was allocated to intangible assets. These amounts are included in other assets on the Company’s balance sheet as of March 31, 2008. The allocations are subject to further adjustment upon finalization of our assessment.
Note 6 — Debt Obligations
On October 1, 2007, Care entered into a master repurchase agreement with Column Financial, Inc., an affiliate of Credit Suisse, one of the underwriters of Care’s initial public offering in June 2007. This type of lending arrangement is often referred to as a warehouse facility. The Agreement provides an initial line of credit of up to $300 million, which may be increased temporarily to an aggregate amount of $400 million under the terms of the Agreement. Care may receive up to 50% of the value of each loan sold based on Column’s underwriting of such loan and will agree to repurchase each loan at a future date. From the time of sale until the time of repurchase, Care pays Column a monthly price differential payment set at 0.75% over LIBOR. Under the terms of the Agreement, this price differential payment will increase to 1% over LIBOR on June 1, 2008.
The term of the Agreement is for three years and may be terminated by Column at any time on not less than one year’s notice. As of March 31, 2008, Care had $38.5 million outstanding under the warehouse line. Interest expense for the three months ended March 31, 2008, was $0.4 million. The effective interest rate on our borrowings under the warehouse line was 4.39% (average one month LIBOR of 3.64% + 0.75%). The $38.5 million outstanding was secured by eight first mortgages with principal balances totaling $116.6 million at March 31, 2008. Care paid approximately $0.1 million in principal amortization during the three months ended March 31, 2008. Costs incurred to establish the warehouse line approximated $0.9 million, are reflected in other assets and will be amortized over the three-year term of the facility. At March 31, 2008, the unamortized balance of deferred financing cos ts approximated $0.7 million.
Dislocations in the global credit markets that arose in the second half of 2007 have persisted well into 2008 and have resulted in significant contraction of liquidity in the marketplace at commercially acceptable terms. In January 2008, Care pledged additional assets to the warehouse facility providing increased availability under the line. On February 19, 2008, the Company utilized $10.2 million from the warehouse line to fund a new mortgage investment and on March 19, 2008, we drew an additional $3.4 million. Pledging existing eligible assets into the warehouse line may provide additional funding availability up to approximately $24 million, subject to the sole discretion and current underwriting standards of our lender. With widespread dislocation in the debt markets persisting well into 2008, we cannot be assured with any certainty that additional funds from the warehouse line will be advanced.
In addition, plans to issue CDOs for more stable longer-term financing are uncertain given continuing turmoil in the CDO market. We cannot foresee when the CDO market may stabilize and do not believe that we will be able to successfully enter into a CDO on terms acceptable to us in the short term. Absent the ability to execute a CDO, our warehouse provider could liquidate the warehoused collateral and we would then have to pay the amount by which the original purchase price of the collateral exceeded its sale price, subject to negotiated caps, if any, on our exposure.
Note 7 — Related Party Transactions
Management Agreement
In connection with our initial public offering in 2007, we entered into a Management Agreement with our Manager, which describes the services to be provided by our Manager and its compensation for those services. Under the Management Agreement, our Manager, subject to the oversight of the Board of Directors of Care, is required to manage the day-to-day activities of the Company, for which the Manager receives a base management fee and is eligible for an incentive fee. The Manager is also entitled to charge the Company for certain expenses incurred on behalf of Care.
13
The Management Agreement has an initial term expiring on June 30, 2010, and will be automatically renewed for one-year terms thereafter unless either we or our Manager elect not to renew the agreement. The base management fee is payable monthly in arrears in an amount equal to 1/12 of 1.75% of the Company’s stockholders’ equity at the end of each month, computed in accordance with GAAP, adjusted for certain items pursuant to the terms of the Management Agreement. Our Manager is also eligible to receive an incentive fee, payable quarterly in arrears based upon performance thresholds stipulated in the Management Agreement.
Our Manager may also be entitled to a termination fee, payable for non-renewal of the Management Agreement without cause, in an amount equal to three times the sum of the average annual base management fee and the average annual incentive fee, both as earned by our Manager during the two years immediately preceding the most recently completed calendar quarter prior to the date of termination. No termination fee is payable if we terminate the Management Agreement for cause.
Care is also responsible for reimbursing the Manager for its pro rata portion of certain expenses detailed in the Management Agreement, such as rent, utilities, office furniture, equipment, and overhead, among others, required for Care’s operations. Transactions with our Manager during the three months ended March 31, 2008 included:
In addition, pursuant to SFAS 123R, we recognized approximately $0.1 million in expense during the quarter, related to the continued vesting of the 148,333 shares of restricted stock granted to our independent board members and Manager’s employees, some of whom are also Care officers and directors, upon our initial public offering in June 2007 (see Note 9).
Note 8 — Fair Value of Financial Instruments
The Company adopted SFAS No. 157, Fair Value Measurements, effective January 1, 2008, and accordingly all assets and liabilities measured at fair value will utilize valuation methodologies in accordance with the statement. The Company has established processes for determining fair values and fair value is based on quoted market prices, where available. If listed prices or quotes are not available, then fair value is based upon internally developed models that primarily use inputs that are market-based or independently-sourced market parameters.
A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of valuation hierarchy established by SFAS 157 are defined as follows:
Level 1 — inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 — inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3 — inputs to the valuation methodology are unobservable and significant to the fair value measurement.
The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy.
Interest rate caps — The fair value of interest rate caps is based on an independent dealer quote.
Obligation to issue operating partnership units — The fair value of our obligation to issue operating partnership units is based on an internally developed valuation model, as quoted market
14
prices are not available nor are quoted prices for similar liabilities. Our model involves the use of management estimates as well as some Level 1 inputs. The variables in the model include time, discount factor, estimated cash flows, and the market price and expected dividend of Care’s common shares.
The following table presents the Company’s financial instruments carried at fair value on the consolidated balance sheet as of March 31, 2008, by SFAS No. 157 hierarchy.
In addition to SFAS No. 157, SFAS No. 107, Disclosures about Fair Value of Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the financial statements, for which it is practical to estimate that value. In cases where quoted market prices are not available, fair value is based upon the application of discount rates to estimated future cash flows based on market yields or other appropriate valuation methodologies. Considerable judgment is necessary to interpret market data and develop estimated fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts we could realize on disposition of the financial instruments. The use of different market assumptions and/or estimation methodologies may have a ma terial effect on the estimated fair value amounts.
Cash equivalents, accrued interest receivable, accounts payable and accrued expenses, and other liabilities reasonably approximate their fair values due to the short maturities of these items.
Investing in healthcare-related commercial mortgage debt is transacted through an over-the-counter market with minimal pricing transparency. Loans are infrequently traded and market quotes are not widely available and disseminated. Our investments in variable rate loans bear interest at stated spreads to a floating base rate (one month LIBOR) and reprice monthly. Management’s estimate of the fair value of our loan investments is approximately $1.6 million less than the principal balance of the portfolio at March 31, 2008.
Borrowings under our warehouse line of credit bear interest at one month LIBOR plus a spread of 75 basis points, which increases to 100 basis points on June 1, 2008. Due to the monthly resetting of interest, Management believes the carrying amount of our borrowings under the warehouse line of credit reasonably approximates fair value.
Note 9 — Stockholders’ Equity
Our authorized capital stock consists of 100,000,000 shares of preferred stock, $0.001 par value and 250,000,000 shares of common stock, $0.001 par value. As of March 31, 2008, no shares of preferred stock were issued and outstanding and 21,023,403 shares of common stock were issued and outstanding.
Equity Plan
At the time of our initial public offering in June 2007, we issued 133,333 shares of common stock with a fair value of approximately $2.0 million to our Manager’s employees, some of whom are
15
officers or directors of Care. We also awarded 15,000 shares of common stock with a fair value of approximately $0.2 million at the time of our initial public offering to Care’s independent board members. The shares granted to our Manager’s employees vest on June 27, 2010, three years from the date of grant. The shares granted to our independent board members vest ratably on the first, second and third anniversaries of the grant. Pursuant to SFAS 123R, we recognized approximately $0.1 million in compensation expense related to these grants in the quarter ended March 31, 2008.
Schedule of Non Vested Shares — Equity Plan
Vesting Schedule
On January 2, 2008, 5,815 shares of common stock with a fair value of approximately $0.1 million were granted to our independent directors as part of their annual retainer. Each independent director receives an annual base retainer of $100,000, payable quarterly in arrears, of which 50% is paid in cash and 50% in common stock of Care. Shares granted as part of the annual retainer vest immediately and are expensed by Care.
As of March 31, 2008, 159,363 shares of our common stock had been granted pursuant to the Equity Plan and 540,637 shares remain available for future issuances. The Equity Plan will automatically expire on the 10th anniversary of the date it was adopted. Care’s Board of Directors may terminate, amend, modify or suspend the Equity Plan at any time, subject to stockholder approval in the case of amendments or modifications.
Manager Equity Plan
Upon completion of our initial public offering in June 2007, we granted 607,690 fully vested shares of our common stock to our Manager under the Manager Equity Plan. These shares are subject to our Manager’s right to register the resale of such shares pursuant to a registration rights agreement we entered into with our Manager in connection with our initial public offering. At March 31, 2008, 717,945 shares are available for future issuances under the Manager Equity Plan. The Manager Equity Plan will automatically expire on the 10th anniversary of the date it was adopted. Care’s Board of Directors may terminate, amend, modify or suspend the Manager Equity Plan at any time, subject to stockholder approval in the case of amendments or modifications.
16
Note 10 — Income per Share (in thousands, except share and per share data)
Diluted income per share was the same as basic income per share for the three months ended March 31, 2008, because all outstanding restricted stock awards were anti-dilutive.
Note 11 — Commitments and Contingencies
Several of our investments in loans have commitment amounts in excess of the amount that we have funded to date on such loans. At March 31, 2008, Care was obligated to provide approximately $5.3 million in additional financing at the request of our borrowers, subject to the borrowers’ compliance with their respective loan agreements, and approximately $2.8 million in tenant improvements related to our purchase of the Cambridge properties.
On September 18, 2007, a class action complaint for violations of federal securities laws was filed in the United States District Court, Southern District of New York alleging that the registration statement relating to the initial public offering of shares of Care Investment Trust Inc.’s common stock, filed on June 21, 2007, failed to disclose that certain of the assets in the contributed portfolio were materially impaired and overvalued and that Care was experiencing increasing difficulty in securing its warehouse financing lines. On January 18, 2008, the court entered an order appointing co-lead plaintiffs and co-lead counsel. On February 19, 2008, the co-lead plaintiffs filed an amended complaint citing additional evidentiary support for the allegations in the complaint. Care believes the complaint and allegations are without merit and intends to defend against the complaint and allegations vigorously. The Company filed a motion to dismiss the complaint on April 22, 2008. However, the outcome of this matter cannot currently be predicted. To date, Care has incurred approximately $0.3 million to defend against this complaint. No provision for loss, if any, related to this matter has been accrued at March 31, 2008.
Care is not presently involved in any other material litigation nor, to our knowledge, is any material litigation threatened against us or our investments, other than routine litigation arising in the ordinary course of business. Management believes the costs, if any, incurred by us related to litigation will not materially affect our financial position, operating results or liquidity.
Note 12 — Financial Instruments: Derivatives and Hedging
The fair value of our obligation to issue operating partnership units was $2.9 million and $3.0 million at December 31, 2007 and March 31, 2008, respectively, resulting in an unrealized loss of $0.1 million for the three months ended March 31, 2008.
On February 1, 2008, we entered into three interest rate caps on three loans pledged as collateral under our warehouse line of credit in order to increase the advance rates available on the pledged loans. The total premium paid for the caps approximated $50,000. Two of the caps have a term of 33 months and the other has a term of nine months. The interest rate caps were fair valued as of the reporting date resulting in an unrealized loss of $21,000.
Note 13 — Subsequent Events
Early Loan Termination
On April 15, 2008 a borrower, upon prior notification to Care, prepaid its current loan obligation of $27.2 million in accordance with the terms of the underlying loan agreement. Proceeds from the repayment also included a pre-payment fee of approximately $0.3 million, which after accounting for
17
the unamortized premium resulting from the initial contribution, resulted in a loss of $0.3 million in relation to our carrying value of the loan. In accordance with SFAS No. 5, Accounting for Contingencies, we have accrued this loss in the three month period ended March 31, 2008.
Declaration of Distribution
On May 12, 2008, the Board of Directors declared a dividend in the amount of $0.17 per share of common stock. The dividend is payable on June 6, 2008 to common stockholders of record on May 23, 2008.
Portfolio Transaction
On May 14, 2008, Care entered into a purchase and sale agreement with the Bickford Senior Living Group to acquire and lease back twelve healthcare facilities (independent living, assisted living, Alzheimer and mixed-use) with 569 units located throughout the midwest. The transaction size is in excess of $100 million and we expect to close on or around the end of June 2008.
18
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
and
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk
The following should be read in conjunction with the consolidated financial statements and notes included herein. This ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations’’ and ‘‘Quantitative and Qualitative Disclosures about Market Risk’’ contain certain non-GAAP financial measures. See ‘‘Non-GAAP Financial Measures’’ and supporting schedules for reconciliation of our non-GAAP financial measures to the comparable GAAP financial measures.
Overview
Care Investment Trust Inc. (all references to ‘‘Care’’, ‘‘the Company’’, ‘‘we’’, ‘‘us’’, and ‘‘our’’ means Care Investment Trust Inc. and its subsidiaries) is a real estate investment trust (‘‘REIT’’) formed principally to invest in healthcare-related commercial mortgage debt and real estate. Care was incorporated in Maryland in March 2007, and we completed our initial public offering on June 27, 2007. We originally positioned the Company as a healthcare REIT to emphasize mortgage investments, while also opportunistically targeting acquisitions of healthcare real estate. Care’s initial investment portfolio at the time of our initial public offering was totally comprised of mortgage loans. In response to dislocations in the overall credit market, in particular the securitized financing markets, we redirect ed our focus in the latter part of 2007 to place greater emphasis on high quality healthcare real estate equity investments. Our shift in investment emphasis was prompted by the dislocations in the CDO (collateralized debt obligations) and CMBS (commercial mortgage backed securities) markets, which have resulted in significant contraction of liquidity available in the marketplace and hampered our original intent to efficiently leverage our mortgage investments through securitized borrowings using our mortgage investments as collateral.
At March 31, 2008, our total investment portfolio of $320.2 million is comprised of $71.1 million in investments in partially-owned entities (22%), $3.0 million invested in a net leased property (1%) and $246.2 million in investments in loans (77%), net of unamortized loan fees. Our current equity investments are in medical office buildings, assisted and independent living facilities, and an Alzheimer facility. Our loan portfolio is primarily composed of first mortgages on skilled nursing facilities, assisted and independent living facilities, and mixed-use facilities. Our ongoing intent is to invest opportunistically in the broad spectrum of healthcare-related real estate, including medical office buildings, senior housing (assisted and independent living facilities, and continuing care communities), hospitals, outpatient centers, surgery centers, laboratories, skilled nursing facilities and other healthcare facilities. Although ou r strategic focus is on equity, the Company has the intent to provide financing, including first mortgages, B Notes, mezzanine loans and construction loans, to meet our clients’ needs across their capital structure, when such investments provide opportunistic returns. This hybrid strategy of focusing on equity investments and making mortgage investments where appropriate provides Care the flexibility to respond to shifts in the healthcare and capital markets to capture value where market opportunities arise.
Care is externally managed and advised by CIT Healthcare LLC (‘‘Manager’’). Our Manager is a healthcare finance company that offers a full-spectrum of financing solutions and related strategic advisory services to companies across the healthcare industry throughout the United States. Our Manager was formed in 2004 and is a wholly-owned subsidiary of CIT Group Inc. (‘‘CIT’’), a leading middle market global commercial finance company that provides financial and advisory services.
Critical Accounting Policies
A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2007 in ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations’’. There have been no significant changes to those policies during the three months ended March 31, 2008.
19
Results of Operations
Care commenced operations on June 22, 2007; therefore, there is no prior year data available for comparison to the results for the three months ended March 31, 2008.
Revenue
We earned investment income on our portfolio of mortgage investments of approximately $4.7 million for the three month period ended March 31, 2008. Our portfolio of mortgage investments are all variable rate instruments, and at March 31, 2008, had a weighted average spread of 3.43% over one month LIBOR, and an average maturity of approximately 3 years. The effective yield on the portfolio for the three months ended March 31, 2008 was 7.85%.
Other income for the three month period ended March 31, 2008, reflects $0.1 million in interest earned on invested cash balances, as well as miscellaneous fees.
Expenses
For the three months ended March 31, 2008, we recorded total related party expenses of approximately $1.3 million consisting of the base management fee payable to our Manager under our management agreement.
Marketing, general and administrative expenses were approximately $1.0 million for the three months ended March 31, 2008 and consist of professional fees, insurance and general overhead costs for the Company. Included in our expenses is stock based non-employee compensation related to our issuance of 133,333 shares of restricted common stock to our Manager’s employees, some of whom are also Care officers or directors, and 15,000 shares to our independent directors with a total fair value of approximately $2.2 million at the time of initial public offering in June 2007. The shares granted to our Manager’s employees vest on June 27, 2010, three years from the date of grant. The shares granted to our independent directors vest ratably over the three years from the anniversary of the date of grant. Pursuant to SFAS 123R, we recognized $0.1 million in expense for the three month period ended March 31,  ;2008 related to these stock grants. The balance of this compensation will be recognized over the remaining vesting period and the amount of the compensation adjusted to fair value at each measurement date pursuant to SFAS 123R. In addition, we paid $0.1 million in stock-based compensation related to shares of our common stock earned by our independent directors as part of their compensation. Each independent director is paid a base retainer of $100,000, which is payable 50% in cash and 50% in stock. Payments are made quarterly in arrears. Shares of our common stock issued to our independent directors as part of their annual compensation vest immediately and are expensed by us accordingly.
The management fees, expense reimbursements, and the relationship between our Manager and us are discussed further in ‘‘Related Party Transactions.’’
We also recorded a $0.3 million loss on the prepayment of an outstanding loan as the $0.3 million prepayment fee received was not sufficient to cover the unamortized purchase premium on the loan.
Loss from investments in partially-owned entities
For the three months ended March 31, 2008, net loss from partially-owned entities amounted to $1.1 million. Our equity in the non-cash operating loss of the Cambridge properties was $1.4 million which was partially offset by our share of equity income in SMC of $0.3 million.
Unrealized losses on derivatives
In addition, we incurred a $0.1 million unrealized loss on the fair value of our obligation to issue partnership units related to the Cambridge transaction, and a $21,000 loss on the fair value of our interest rate caps. See Notes 4 and 12 for more information.
Interest Expense
We increased our borrowings under our warehouse line of credit to $38.5 million and incurred interest expense of approximately $0.4 million. In order to increase our net income and the cash flows
20
available to pay dividends to our stockholders, we intend to pursue a strategy of acquiring additional investments by leveraging our portfolio of investments through our warehouse line, dedicated asset financing and other borrowings.
Cash Flows
Cash and cash equivalents were $14.9 million at March 31, 2008, down from $15.3 million at December 31, 2007. The $0.4 million decrease was largely attributable to investment activity during the three months ended March 31, 2008 of $12.6 million. Cash flow from operations for the first quarter of 2008 provided $2.3 million and net financing activities contributed an additional $9.9 million.
Net cash provided by operating activities for the quarter ended March 31, 2008 amounted to $2.3 million. Net income before adjustments provided $0.5 million. Equity in the operating results of, and distributions from, investments in partially-owned entities added $1.3 million, and a non-cash loss on a prepaid loan provided $0.3 million. Non-cash charges for amortization of loan premium and deferred financing cost, offset by amortization of deferred loan fees, contributed $0.2 million, and stock-based compensation provided an additional $0.2 million, as did unrealized losses on derivatives. The net change in operating assets and liabilities used $0.4 million in cash flow and consisted of a $0.7 million increase in other assets and a $0.7 million reduction in accounts payable and accrued expenses, offset by $0.4 million in accrued interest collected and a $0.6 million increase in other liabilities. The increase in other assets substantially resulted from $0.6 million in intangibles and equipment related to our investment in a net leased property during the period. The $0.7 million decrease in accounts payable and accrued expenses reflects payment of previously accrued expenses. The increase in other liabilities is largely attributable to a $0.4 million increase in borrowers’ deposits.
Net cash used in investing activities for the three month period ended March 31, 2008 totaled $12.6 million and was primarily used to extend new loans and additional advances to existing borrowers for $10.7 million, net of $0.2 million of origination fees, and to fund a $3.0 million investment in net leased properties. Principal amortizations on our mortgage portfolio provided $1.2 million and we incurred an additional $0.1 million in deferred expenses related to our investments in partially-owned entities.
Net cash provided by financing activities for the first quarter of 2008 of approximately $9.9 million resulted from additional draw downs on our warehouse line of credit amounting to $13.6 million, offset by dividend payments of $3.6 million. In addition, we made principal payments on the warehouse line of approximately $0.1 million and deferred additional expenditures related to the warehouse line.
Liquidity and Capital Resources
Liquidity is a measurement of our ability to meet potential cash requirements, including ongoing commitments to repay borrowings, fund and maintain loans and other investments, pay dividends and other general business needs. Our primary source of funds for liquidity was provided by funds we raised in our initial public offering in June 2007. Additional sources of liquidity are net cash provided by operating activities, repayment of principal by our borrowers in connection with our loans and investments, asset-specific borrowings, borrowings under our warehouse facility, the issuance by us or special purpose vehicles owned by us of fixed income securities collateralized by certain of our investments and the issuance by us of preferred equity offerings or follow-on offerings of common equity. We believe that we have adequate liquidity to continue to operate for at least the next twelve months, even given the credit market dislocation described below .
As of March 31, 2008, the Company had $14.9 million in cash and cash equivalents, including $3.0 million related to customer deposits maintained in an unrestricted account. In addition, Care has commitments at March 31, 2008 to extend credit or finance tenant improvements in 2008 amounting to $2.8 million (See Note 13). Under the terms of the Master Repurchase Agreement for our warehouse line of credit with Column Financial, Inc., Care is required to maintain minimum liquidity of
21
$10 million under the current level of the line usage. On April 15, 2008, Care received a $27.5 million prepayment from a borrower consisting of $27.2 million in principal and a $0.3 million prepayment fee (see Note 13). The Company intends to utilize these funds to make future real estate equity investments and to fund operations. In addition, the Company continues to seek other financing sources, including asset specific debt and leveraging unencumbered assets to secure additional borrowings.
Since our initial public offering in June 2007, liquidity in the global credit markets has been curtailed and interest rate spreads have widened significantly. Dislocations in the global credit markets, including securitized financing vehicles such as short-term warehouse facilities and longer-term structures such as CDOs and CMBS, have resulted in significant contraction of liquidity available. Consequently, the advance rates under the warehouse facility are more restrictive than initially anticipated.
As of December 31, 2007, the Company pledged five mortgage loans with a total principal balance of $92.3 million into the warehouse line and had $25.0 million in borrowings outstanding under the line which was used to partially fund our investments in Cambridge and SMC. In January 2008, Care pledged additional assets to the warehouse line providing increased availability under the line, and on February 19, 2008, utilized $10.2 million in additional borrowings to fund a new mortgage investment. On March 19, 2008, we drew another $3.4 million on the warehouse line. Pledging additional eligible assets into the warehouse line may provide additional funding availability up to approximately $24 million, subject to the sole discretion and current underwriting standards of our lender. With widespread dislocation in the debt markets persisting well into 2008, we cannot be assured with any certainty that addition al funds from the warehouse facility will be advanced. In addition, should we not be able to consummate a securitization transaction, our warehouse provider could liquidate the warehoused collateral and we would have to pay any amount by which the original purchase price of the collateral exceeds its sale price, subject to negotiated caps, if any, on our exposure. Regardless of whether a securitization transaction is consummated, if any warehoused collateral is sold before the consummation, we will have to bear any resulting loss on sale. This disruption in the credit markets may impede our ability to grow in the short term. Should the Company not be able to draw credit on or experience reduced availability on our existing warehouse line, face margin calls and other constraints on credit availability at the subjective discretion of our lender, or consummate a securitization, Care may not be able to continue to operate profitably, make payments on our existing obligations, fund commitments, make new investmen ts, or pay dividends.
Our ability to meet our long-term liquidity and capital resource requirements will be subject to obtaining additional debt financing and equity capital. We cannot anticipate when credit markets will stabilize and liquidity becomes available. Our actual leverage will depend on our mix of investments and the cost and availability of leverage. If we are unable to renew, replace or expand our sources of financing, it may have an adverse effect on our business, results of operations, and ability to make distributions to our stockholders. Any indebtedness we incur will likely be subject to continuing covenants and we will likely be required to make continuing representations and warranties about our company in connection with such debt. Our debt financing terms may require us to keep un-invested cash on hand, or to maintain a certain portion of our assets free of liens, each of which could serve to limit our borrowing ability. Moreover, our debt ma y be secured by our assets. If we default in the payment of interest or principal on any such debt, breach any representation or warranty in connection with any borrowing or violate any covenant in any loan document, our lender may accelerate the maturity of such debt requiring us to immediately repay all outstanding principal. If we are unable to make such payment, our lender could foreclose on our assets that are pledged as collateral to such lender. The lender could also sue us or force us into bankruptcy. Any such event would have a material adverse effect on our liquidity and the value of our common stock. In addition, posting additional collateral to support our credit facilities will reduce our liquidity and limit our ability to leverage our assets.
To maintain our status as a REIT under the Internal Revenue Code, we must distribute annually at least 90% of our REIT taxable income. These distribution requirements limit our ability to retain earnings and thereby replenish or increase capital for operations. However, we believe that, when the
22
credit markets return to more historically normal conditions, our capital resources and access to financing will provide us with financial flexibility at levels sufficient to meet current and anticipated capital requirements, including funding new lending and investment opportunities, paying distributions to our stockholders and servicing our debt obligations.
Capitalization
As of March 31, 2008, we had 21,023,403 shares of common stock outstanding.
Quantitative and Qualitative Disclosures about Market Risk
Market risk includes risks that arise from changes in interest rates, commodity prices, equity prices and other market changes that affect market sensitive instruments. In pursuing our business plan, we expect that the primary market risks to which we will be exposed are real estate and interest rate risks.
Real Estate Risk
The value of owned real estate, commercial mortgage assets and net operating income derived from such properties are subject to volatility and may be affected adversely by a number of factors, including, but not limited to, national, regional and local economic conditions which may be adversely affected by industry slowdowns and other factors, local real estate conditions (such as an oversupply of retail, industrial, office or other commercial space), changes or continued weakness in specific industry segments, construction quality, age and design, demographic factors, retroactive changes to building or similar codes, and increases in operating expenses (such as energy costs). In the event net operating income decreases, or the value of property held for sale decreases, a borrower may have difficulty paying our rent or repaying our loans, which could result in losses to us. Even when a property’s net operating income is sufficient to cover the propert y’s debt service, at the time an investment is made, there can be no assurance that this will continue in the future.
The current turmoil in the residential mortgage market may continue to have an effect on the commercial mortgage market and real estate industry in general.
Interest Rate Risk
Interest rate risk is highly sensitive to many factors, including the availability of liquidity, governmental monetary and tax policies, domestic and international economic and political considerations and other factors beyond our control.
Our operating results will depend in large part on differences between the income from assets in our mortgage loan portfolio and our borrowing costs. Most of our loan assets and borrowings are expected to be variable-rate instruments that we will finance with variable rate debt. The objective of this strategy is to minimize the impact of interest rate changes on the spread between the yield on our assets and our cost of funds. Although we have not done so to date, we may enter into hedging transactions with respect to liabilities relating to fixed rate assets in the future. If we were to finance fixed rate assets with variable rate debt and the benchmark for our variable rate debt increased, our net income would decrease. Furthermore, as our current financing allows the lender to mark our assets to market and make margin calls based on a change in the value of our assets, financing fixed rate assets with floating rate debt would create t he risk that an increase in fixed rate benchmarks (such as ‘‘swap’’ yields) would decrease the value of our fixed rate assets. Some of our loans may be subject to various interest rate floors. As a result, if interest rates fall below the floor rates, the spread between the yield on our assets and our cost of funds will increase, which will generally increase our returns.
23
At present, our portfolio of variable rate mortgage loans is substantially funded by our equity as restrictive conditions in the securitized debt markets have not enabled us to leverage the portfolio through our warehouse line as we originally intended. Accordingly, the income we earn on these loans is subject to variability in interest rates. At current investment levels, changes in interest rates at the magnitudes listed would have the following estimated effect on our annual income from investments in loans:
In the event of a significant rising interest rate environment and/or economic downturn, delinquencies and defaults could increase and result in credit losses to us, which could adversely affect our liquidity and operating results. Further, such delinquencies or defaults could have an adverse effect on the spreads between interest-earning assets and interest-bearing liabilities.
Our funding strategy involves leveraging our loan investments through borrowings, generally through the use of warehouse facilities, bank credit facilities, repurchase agreements, secured loans, securitizations, including the issuance of CDOs or CMBS, loans to entities in which we hold, directly or indirectly, interests in pools of assets, and other borrowings. In the short term we intend to use warehouse lines of credit, to the extent available, to finance the acquisition of assets as well as utilizing asset-specific debt. Currently, the availability of liquidity through CDOs is very limited due to investor concerns over dislocations in the debt markets, hedge fund losses, the large volume of unsuccessful leveraged loan syndications and related impact on the overall credit markets. These concerns have materially impacted liquidity in the debt markets, making financing terms for borrowers significantly less attractive. We cannot foresee when credit markets may s tabilize and liquidity becomes available. A prolonged downturn in the term CDO and CMBS markets may cause us to seek alternative sources of potentially less attractive financing, and may impede our ability to grow the Company in accordance with our business plan.
Contractual Obligations
Under our Management Agreement entered into in connection with our public offering, our Manager, subject to the oversight of the Company’s Board of Directors, is required to manage the day-to-day activities of Care, for which the Manager receives a base management fee and is eligible for an incentive fee. The Management Agreement has an initial term expiring on June 30, 2010, and will be automatically renewed for one-year terms thereafter unless either we or our Manager elect not to renew the agreement. The base management fee is payable monthly in arrears in an amount equal to 1/12 of 1.75% of the Company stockholders’ equity at the end of each month, computed in accordance with GAAP, adjusted for certain items pursuant to the terms of the agreement. Our Manager is also eligible to receive an incentive fee, payable quarterly in arrears, based upon performance thresholds stipulated in the Management Agreement. For the period quarter ended M arch 31, 2008, we recognized $1.3 million in management fee expense related to the base management fee, and our Manager was not eligible for an incentive fee.
In addition, our Manager may be entitled to a termination fee, payable for non-renewal of the Management Agreement without cause, in an amount equal to three times the sum of the average annual base fee and the average annual incentive fee, both as earned by our Manager during the two years immediately preceding the most recently completed calendar quarter prior to the date of termination. No termination fee is payable if we terminate the Management Agreement for cause.
24
On October 1, 2007, Care entered into a master repurchase agreement with Column Financial, Inc., an affiliate of Credit Suisse, for short-term financing through a warehouse facility. The Agreement provides an initial line of credit up to $300 million. Under the terms of the Agreement, Care may receive up to 50% of the value of each loan sold into the warehouse based on Column’s underwriting of such loan and will agree to repurchase each loan at a future date. The term of the Agreement is for three years and may be terminated by Column at any time on not less than one year’s notice. In addition, Column has the right to issue margin calls in certain situations which Care must satisfy in cash within one business day. The Agreement also requires the Company to maintain certain financial covenants. From the time of sale until the time of repurchase, Care is required to pay Column a monthly price differential payment set at one month LI BOR + 0.75%. Under the terms of the Agreement, this price differential will increase to 1% over LIBOR on June 1, 2008. In addition, partial amortization of the principal borrowed is required. As of March 31, 2008, the Company had $38.5 million in borrowings under the facility.
The table below summarizes our contractual obligations as of March 31, 2008 (Amounts in millions).
We are required to make monthly amortization payments on our borrowings under our warehouse facility with Column Financial. Estimated amortizations based on experience to date are included in the table for 2008 and 2009, with the balance due in 2010 at the expiration of the facility. Interest on our borrowing under the warehouse line is not included in the table because it is not fixed and determinable. The estimated amounts and timing of the commitments to fund loans presented above are based on projections based on data provided by borrowers. The projections are subject to adjustments based on changes in borrowers’ needs. The estimated amounts and timing of the commitments to fund tenant improvements are based on projections by the property managers who are affiliates of Cambridge. We have estimated amounts due to our Manager under the Management Agreement based on experience to date and estimates of our capital position in the near-term, until the expir ation of the agreement in June 2010.
Off-Balance Sheet Arrangements
As of March 31, 2008, we had no off-balance sheet arrangements.
Dividends
To maintain our qualification as a REIT, we must pay annual dividends to our stockholders of at least 90% of our REIT taxable income, determined before taking into consideration the dividends paid deduction and net capital gains. We intend to pay regular quarterly dividends to our stockholders. Before we pay any dividend, whether for Federal income tax purposes or otherwise, which would only be paid out of available cash to the extent permitted under our secured credit facility, we must first meet both our operating requirements and any scheduled debt service on our outstanding borrowings.
Related Party Transactions
Contribution Agreement
We and our Manager entered into a contribution agreement, pursuant to which our Manager contributed a portfolio of initial assets to us and we issued to our Manager shares of our common stock and cash. Our Manager determined that the fair value of the assets contributed was approximately $283.1 million on June 27, 2007 inclusive of approximately $4.6 million in premium.
25
The initial assets were acquired in exchange for approximately $204.3 million in cash from the proceeds of our initial public offering and 5,256,250 restricted shares of our common stock at a fair value of approximately $78.8 million. We recorded each initial asset we purchased at its estimated fair value.
In connection with our initial public offering, we entered into a Management Agreement with our Manager which describes the services to be provided by our Manager and its compensation for those services. Under the Management Agreement, our Manager, subject to the oversight of our board of directors, is required to conduct our business affairs in conformity with the policies and the investment guidelines that are approved by our board of directors. The Management Agreement has an initial term expiring on June 30, 2010, and will automatically be renewed for one-year terms thereafter unless terminated by us or our Manager.
Please see Note 7. Related Party Transactions — Management Agreement in the Notes to Consolidated Financial Statements in Part I — Item 1 for a summary description of the compensation, fees and costs payable to our Manager.
Transactions with our Manager included:
In addition, pursuant to SFAS 123R, we recognized approximately $0.1 million in expense during the quarter, related to the continuing vesting of the 148,333 shares of restricted stock granted to our independent board members and Manager’s employees, some of whom are also Care officers and directors, at our initial public offering in June 2007 (see Note 9).
Non-GAAP Financial Measures
Funds from Operations
Funds from Operations, or FFO, which is a non-GAAP financial measure, is a widely recognized measure of REIT performance. We compute FFO in accordance with standards established by the National Association of Real Estate Investment Trusts, or NAREIT, which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we do.
The revised White Paper on FFO, approved by the Board of Governors of NAREIT in April 2002 defines FFO as net income (loss) (computed in accordance with GAAP), excluding gains (or losses) from debt restructuring and sales of properties, plus real estate related depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.
Adjusted Funds from Operations
Adjusted Funds from Operations, or AFFO, is a non-GAAP financial measure. We compute AFFO in accordance with our Management Agreement’s definition of FFO and as such it may not be comparable to AFFO reported by other REITs that do not compute AFFO on the same basis. Our management agreement defines FFO, for purposes of the agreement, to mean net income (loss) (computed in accordance with GAAP), excluding gains (losses) from debt restructuring and gains (losses) from sales of property, plus depreciation and amortization on real estate assets and non-cash equity compensation expense, and after adjustments for unconsolidated partnerships and joint ventures; provided, that the foregoing calculation of Funds From Operations shall be adjusted to
26
exclude one-time events pursuant to changes in GAAP and may be adjusted to exclude other non-cash charges after discussion between the Manager and the independent directors, and approval by the majority of the independent directors in the case of non-cash charges.
FFO and AFFO
We believe that FFO and AFFO are helpful to investors as measures of the performance of a REIT because, along with cash flow from operating activities, financing activities and investing activities, FFO and AFFO provide investors with an indication of our ability to incur and service debt, to make investments and to fund other cash needs. AFFO, as defined in our agreement with our Manager, also provides the basis for the computation of the amount of the Management Incentive Fee payable to our Manager.
Neither FFO nor AFFO represent cash generated from operating activities in accordance with GAAP and they should not be considered as an alternative to net income (determined in accordance with GAAP), as an indication of our financial performance or cash flow from operating activities (determined in accordance with GAAP), as a measure of our liquidity, nor are they indicative of funds available to fund our cash needs, including our ability to make cash distributions.
FFO and AFFO for the three months ended March 31, 2008 were as follows (in thousands except per share data):
Forward-Looking Information
We make forward looking statements in this Form 10-Q that are subject to risks and uncertainties. These forward looking statements include information about possible or assumed future results of our business and our financial condition, liquidity, results of operations, plans and objectives. They also include, among other things, statements concerning anticipated revenues, income or loss, capital expenditures, dividends, capital structure, or other financial terms, as well as statements regarding subjects that are forward looking by their nature, such as:
• our business and financing strategy;
• our ability to obtain future financing arrangements;
• our ability to acquire investments on attractive terms;
• our understanding of our competition;
• our projected operating results;
27
• market trends;
• estimates relating to our future dividends;
• completion of any pending transactions;
• projected capital expenditures; and
• the impact of technology on our operations and business.
The forward looking statements are based on our beliefs, assumptions, and expectations of our future performance, taking into account the information currently available to us. These beliefs, assumptions, and expectations can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity, and results of operations may vary materially from those expressed in our forward looking statements. You should carefully consider this risk when you make a decision concerning an investment in our securities, along with the following factors, among others, that could cause actual results to vary from our forward looking statements:
When we use words such as ‘‘will likely result,’’ ‘‘may,’’ ‘‘shall,’’ ‘‘believe,’’ ‘‘expect,’’ ‘‘anticipate,’’ ‘‘project,’’ ‘‘intend,’’ ‘‘estimate,’’ ‘‘goal,’’ ‘‘objective,’’ or similar expressions, we intend to identify forward looking statements. You should not place undue reliance on these forward looking statements. We are not obligated to publicly update or revise any forward looking statements, whether as a result of new information, future events, or otherwise.
28
Item 4T. Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Notwithstanding the foregoing, no matter how well a control system is designed and operated, it can provide only reasonable, not absolute, assurance that it will detect or uncover failures within our company to disclose material information otherwise required to be set forth in our periodic reports.
As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
Changes in Internal Controls over Financial Reporting
There has been no change in our internal control over financial reporting during the three months ended March 31, 2008 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Sarbanes-Oxley 404 Reporting
We are not required to comply with all of the rules and regulations of the Securities and Exchange Commission, particularly the requirement that we include in our annual report on Form 10-K a report of management and accompanying auditor’s report on the Company’s internal control over financial reporting (‘‘404 reporting’’). Compliance by the Company with the 404 reporting rules and regulations will be required in our annual report on Form 10-K for the fiscal year ending December 31, 2008, unless the rules and regulations governing 404 reporting are revised.
29
Part II. Other Information
ITEM 1. Legal Proceedings
On September 18, 2007, a class action complaint for violations of federal securities laws was filed in the United States District Court, Southern District of New York alleging that the Registration Statement relating the initial public offering of shares of Care Investment Trust Inc.’s common stock, filed on June 21, 2007, failed to disclose that certain of the assets in the contributed portfolio were materially impaired and overvalued and that Care was experiencing increasing difficulty in securing its warehouse financing lines. On January 18, 2008, the court entered an order appointing co-lead plaintiffs and co-lead counsel. On February 19, 2008, the co-lead plaintiffs filed an amended complaint citing addition evidentiary support for the allegations in the complaint. Care believes the complaint and allegations are without merit and intends to defend against the complaint and allegations vigorously. The Company filed a motion to dismi ss the complaint on April 22, 2008. However, the outcome of this matter cannot currently be predicted. To date, Care has incurred approximately $0.3 million to defend against this complaint. No provision for loss, if any, related to this matter has been accrued at March 31, 2008.
ITEM 1A. Risk Factors
Risk Factors
There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K as of December 31, 2007 filed with the Securities and Exchange Commission.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
ITEM 5. Other Information
On May 12, 2008, the Compensation Committee (the ‘‘Committee’’) of the Board of Directors of Care Investment Trust Inc. (the ‘‘Company’’) approved two new long-term equity incentive programs under the Care Investment Trust Inc. Equity Incentive Plan. The first program is an annual performance-based restricted stock unit (‘‘RSU’’) award program (the ‘‘RSU Award Program’’) and the second program is a three-year performance share plan (the ‘‘Performance Share Plan’’). Achievement of awards under the 2008 RSU Award Program will be based upon the Company’s ability to meet both financial (AFFO per share) and strategic (shifting from a mortgage to an equity REIT) performance goals, as well as on the individual employee’s ability to meet individual performance goals. All of the Company’s executive officers have been granted the right to receive an award under the 2008 RSU Program, the actual amount of which will depend on Company and individual performance in 2008. Performance under the 2008 RSU Award Program will be measured at the end of the performance period (December 31, 2008) and the RSUs in respect of such 2008 performance period will be granted in early 2009. Once granted, the RSUs will be subject to time-based vesting restrictions and will vest in equal installments on each of the first four anniversaries of the grant date.
Under the Performance Share Plan, a participant is granted a number of performance shares or units, the settlement of which will depend on the Company’s achievement of certain pre-determined financial goals at the end of the three-year performance period. Any shares received in settlement of the performance award will be issued to the participant in early 2011, without any further vesting requirements. With respect to the 2008-2010 performance period, the performance goals relate to the
30
Company’s ability to meet both financial (compound growth in AFFO per share) and share return goals (total shareholder return versus the Company’s healthcare equity and mortgage REIT peers). The Committee has established threshold, target and maximum levels of performance. If the Company meets the threshold level of performance, a participant will earn 50% of the performance share grant, if it meets the target level of performance, a participant will earn 100% of the performance share grant and if it achieves the maximum level of performance, a participant will earn 200% of the performance share grant. Currently, only F. Scott Kellman, the Company’s President and Chief Executive Officer, is eligible to receive an award under the 2008-2010 Performance Share Plan. On May 12, 2008, the Committee awarded Mr. Kellman a target award of 23,255 performance shares, with the opportunity to earn a maximum of 46,510 shares and a minimum of 11,627 shares, depending on actual performance measured at the end of the 2008-2010 performance period.
ITEM 6. Exhibits
Except as indicated by an asterisk (*), the following exhibits are filed herewith as part of this Form 10-Q.
(a) Exhibits
31
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
May 15, 2007
32
EXHIBIT INDEX
33